MyAverix Finance
F · Healthcare
HBM HLDGS LTD DL-000025 (6XY)
Biotechnology
HBM HLDGS LTD DL-000025 (6XY) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 6XY
HBM HLDGS LTD DL-000025 (6XY) — FAQ
What is 6XY's P/E ratio?
The price-to-earnings (P/E) ratio for HBM HLDGS LTD DL-000025 (6XY) is 25.00 (data as of 2026-05-23).
Does HBM HLDGS LTD DL-000025 pay a dividend?
Dividend yield is not available in the current snapshot for HBM HLDGS LTD DL-000025 (6XY). Check the MyAverix Finance app for the latest dividend data.
What sector is HBM HLDGS LTD DL-000025 in?
HBM HLDGS LTD DL-000025 (6XY) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 6XY listed on?
6XY is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.